Delaware Business Times Editor Katie Tabeling looks at the challenges many bioscience start-up companies face that seek to push boundaries in medical and scientific research.
Synnovation Therapeutics, a precision oncology startup based out of the Experimental Station in Wilmington has emerged with $102 million financing last week.
Cellergy Pharma, a rising cellular therapies biotechnology company, has been awarded $300,000 to fuel the development of therapies to treat severe allergic diseases.
